Vertex Pharmaceuticals Incorpor

Q1 2020 vs. Q4 2020 13F Holders

Period
Q1 2020
Q4 2020
Num holders
915
1,029
Total reported value, excl. options
$59.0 B
$57.3 B
Total shares, excl. options
248,162,744
240,753,330
Manager Q1 2020
Shares 		Q4 2020
Shares 		Diff Chg %